99% Savings - Buy Just @1 Rs X
Wosulin Pen Royale Device is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Wosulin Pen Royale Device safe for pregnant women?
Wosulin is safe to take during pregnancy.
Is the use of Wosulin Pen Royale Device safe during breastfeeding?
There is no research available on the side effects of Wosulin in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Wosulin Pen Royale Device on the Kidneys?
Wosulin rarely affects the kidneys.
What is the effect of Wosulin Pen Royale Device on the Liver?
Wosulin is rarely harmful for the liver.
What is the effect of Wosulin Pen Royale Device on the Heart?
Wosulin may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Wosulin Pen Royale Device unless your doctor advises you to do so -
Is this Wosulin Pen Royale Device habit forming or addictive?
Forming a habit of Wosulin Pen Royale Device has not been reported.
Interaction between Food and Wosulin Pen Royale Device
Due to a lack of research, nothing can be said about the consequences of taking Wosulin Pen Royale Device together with food.
Interaction between Alcohol and Wosulin Pen Royale Device
Drinking alcohol while taking Wosulin Pen Royale Device may lead to slight side effects. If you experience any side effects, contact your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Novolin® N (Human Insulin Isophane)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Humulin® N (Human Insulin Isophane)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 693-695
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 265
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Humulin® R (regular insulin human)